Ruxolitinib in Patients With Breast Cancer
Clinical trial NCT01562873 · TERMINATED
Trial details
- NCT number
- NCT01562873
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2015-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.